LogicMark, Inc.

LGMK Healthcare Health Information Services

LogicMark, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.4 million, up 15.4% from fiscal 2024. In the quarter to June 2026, revenue grew 17.4%, EPS grew 35.4% and free cash flow grew 96.4%, each against the same quarter a year earlier.

1.30 0.10 +8.33%
Market cap
$1.7M
P/E
0.0×
Fwd P/E
−0.2×
Dividend yield
—
F-score
5/9
Altman Z
−8.13
Beneish M
−2.77
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
0.04 0.04 0.04 0.16
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
6.16 (0.30) (0.25) (2.28)
P/B ratio
0.04 0.03 0.03 0.10
Price to Tangible BV
0.06 0.05 0.04 0.14
EV/Sales
(0.16) (0.24) (0.44) (0.56)
EV/EBITDA
0.49 0.61 0.87 0.91
EV/Operating CF
0.52 0.58 0.99 1.33
EV/FCF
0.11 0.14 0.25 0.30
Quick Ratio
3.73 4.71 4.93 4.86
Current Ratio
4.88 6.30 6.00 5.61
Net Debt/EBITDA
6.75 8.51 8.91 9.49
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
0.62 0.55 0.66 0.55
Operating CF/Net income
(0.05) 1.08 0.98 0.45
Capex/Depreciation
(0.69) (0.48) (0.55) (0.85)
Research and Development Expense of Revenue
2.73% 3.84% 5.29% 5.54%
Selling, General and Administrative Expense of Revenue
85.87% 81.28% 86.45% 89.44%
Intangible Assets out of Total Assets
0.25 0.24 0.22 0.21
Share Based Compensation of Revenue
12.89% 2.48% 8.85% 4.76%
Graham Net Nets
9.42 13.00 18.19 5.20
Graham Number
0.00 0.00 0.00 3,675.52
Earnings Yield
(1,343.86%) (1,601.91%) (14,182.61%) 1,170,687.19%
Free Cash Flow Yield
(3,778.81%) (4,199.34%) (4,904.67%) (1,148.55%)
Revenue per Share
3.72 3.55 5.15 3.79
Operating CF per Share
0.09 (1.82) (2.76) (0.99)
Capex per Share
(0.47) (0.33) (0.56) (0.56)
Free Cash Flow per Share
(0.38) (2.15) (3.31) (1.55)
Cash per Share
7.37 8.26 15.99 15.21
Shareholders Equity per Share
14.66 16.38 27.37 23.21
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
14.66 16.38 27.37 23.21
Free Cash Flow
(0.34) (1.95) (1.97) (1.19)
Working Capital
6.89 8.44 9.67 11.11
Capital Expenditures
(0.42) (0.30) (0.33) (0.43)
Net Current Asset Value
4.83 6.36 7.58 8.98
EV/EBIT
0.32 0.42 0.64 0.70
Capex to Sales
0.13 0.09 0.11 0.15
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
0.08 0.12 0.01 0.06
Average Payables
0.54 0.65 0.66 0.60
Average Inventory
0.99 1.27 1.22 0.93
Average Assets
20.24 21.86 17.26 19.21
Average Common Equity
16.14 17.70 12.78 14.78

Fold the line items

Columns are period end dates